Condition: Rectal Cancer · Sponsor: Ralf Hofheinz
This is a multicenter, prospective, randomized, stratified, controlled, open-label study comparing preoperative FOLFOX versus postoperative risk-adapted chemotherapy in patients with locally advanced rectal cancer and low risk for local failure
This description comes directly from the study's public registry record.
Ralf-Dieter Hofheinz, Prof. Dr. · +49 621 383 · ralf.hofheinz@umm.de
Michelle Tez · +49 69 5899 787 · tez.michelle@ikf-khnw.de
Always discuss trial participation with your own doctor first.
| Unversity Hospital Mannheim | Mannheim, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04495088